Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

REGNBullishAnalyst Target Updateanalyst

Medium materiality6/10

Guggenheim Raises Regeneron Price Target to $1,100

Nov 2, 2026, 7:23 PM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The raised target indicates a constructive analyst view with meaningful implied upside, though it remains a single analyst opinion.

AI summary

What happened, with direct paths to the underlying reporting

Guggenheim raised its Regeneron price target to $1,100, versus the posted price of $927.89, implying about 19% upside.

Guggenheim's $1,100 target is about 19% above the posted price of $927.89.
REGN had gained 3.6% since the signal.

Key facts

01
Target: $1,100
02
Posted price: $927.89
03
Analyst firm: Guggenheim
04
Analyst: Yatin Suneja

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Guggenheim Raises Regeneron Price Target to $1,100

Key facts

Bank of America Lifts REGN Target to 1,030, Signaling Upside

Regeneron poised for strong Q3 with BARDA extension boosts outlook

Regeneron Extends Ebola Treatment Supply Agreement Amid Africa Outbreak

Regeneron's Pasatru PAS Finds Durable 84-Week Efficacy in FOP